Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3211]

ASCO 2010: Bevacizumab prolongs progression-free survival for advanced ovarian cancer

ASCO 2010: Bevacizumab prolongs progression-free survival for advanced ovarian cancer

ASCO 2010: Cetuximab does not improve survival among stage III colon cancer patients with normal KRAS

ASCO 2010: Cetuximab does not improve survival among stage III colon cancer patients with normal KRAS

ASCO 2010: Single does radiation therapy could be the new standard in breast cancer

ASCO 2010: Single does radiation therapy could be the new standard in breast cancer

ASCO 2010: Novel targeted agent for children with drug-resistant medulloblastoma

ASCO 2010: Novel targeted agent for children with drug-resistant medulloblastoma

ASCO 2010: No prevention benefit of selenium for secondary tumours in non-small cell lung cancer

ASCO 2010: No prevention benefit of selenium for secondary tumours in non-small cell lung cancer

ASCO 2010: Novel ALK inhibitor shows high response rate in patients with advanced NSCLC with specific ALK gene alteration

ASCO 2010: Novel ALK inhibitor shows high response rate in patients with advanced NSCLC with specific ALK gene...

ASCO 2010: Paclitaxel and carboplatin combo increases survival in advanced lung cancer in elderly

ASCO 2010: Paclitaxel and carboplatin combo increases survival in advanced lung cancer in elderly

ASCO 2010: Targeted intraoperative radiotherapy is as good as whole breast radiotherapy at reducing breast cancer recurrence

ASCO 2010: Targeted intraoperative radiotherapy is as good as whole breast radiotherapy at reducing breast cancer...

Addition of Vandetanib improves progression-free survival in patients with the most common form of lung cancer

Addition of Vandetanib improves progression-free survival in patients with the most common form of lung cancer

Process of cancer cell self-digestion is target of new cancer therapies

Process of cancer cell self-digestion is target of new cancer therapies

More from ecancer